BETA-BLOCKER CONTAINING PYRAZOLO(1,5-A)PYRIDINE COMPOUND

PURPOSE: To obtain a β-blocker useful for the prevention and treatment of arrhythmia, stenocardia, asthma, migraine, hypertension, glaucoma, hypertonia bulbi, etc. CONSTITUTION: This β-blocker contains 1-(isopropylamino)-3-(pyrazolo[1,5- a]pyrido-4-yloxy)-2-propanol of the formula or its salt. The c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	MIYAZEKI KUNIHIRO
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PURPOSE: To obtain a β-blocker useful for the prevention and treatment of arrhythmia, stenocardia, asthma, migraine, hypertension, glaucoma, hypertonia bulbi, etc. CONSTITUTION: This β-blocker contains 1-(isopropylamino)-3-(pyrazolo[1,5- a]pyrido-4-yloxy)-2-propanol of the formula or its salt. The compound is properly compounded with conventional pharmaceutical components and formed in the form of tablet, granule, powder, capsule, ointment, injection, syrup, eye lotion, nasal drop, etc. The administration rate of the compound is 1-30mg/dose and once a day by injection for adult, 1-100mg/dose and several doses a day by oral administration or a few drops per time and once or several times a day in the form of eye drop having a concentration of 0.01-0.5(w/v)%.